H
Hospital Corporation of China Ltd
HKEX:3869
Hospital Corporation of China Ltd
HKEX:3869
Price:
3.5
HKD
Market Cap:
HK$483.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
H
|
Hospital Corporation of China Ltd
HKEX:3869
|
CN |
|
Yalla Group Ltd
NYSE:YALA
|
AE |
|
S
|
Suzhou TA&A Ultra Clean Technology Co Ltd
SZSE:300390
|
CN |
|
Life Corp
TSE:8194
|
JP |
Income Statement
Earnings Waterfall
Hospital Corporation of China Ltd
Hospital Corporation of China Ltd
Income Statement
Hospital Corporation of China Ltd
Hospital Corporation of China Ltd
Currency: CNY
| Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||
| Interest Expense |
16
|
14
|
15
|
15
|
13
|
11
|
6
|
5
|
9
|
9
|
6
|
6
|
6
|
0
|
0
|
|
| Revenue |
384
N/A
|
418
+9%
|
411
-2%
|
383
-7%
|
399
+4%
|
426
+7%
|
520
+22%
|
854
+64%
|
1 143
+34%
|
1 320
+15%
|
1 428
+8%
|
1 429
+0%
|
1 442
+1%
|
1 466
+2%
|
1 471
+0%
|
|
| Gross Profit | ||||||||||||||||
| Cost of Revenue |
(231)
|
(235)
|
(237)
|
(213)
|
(205)
|
(213)
|
(306)
|
(667)
|
(992)
|
(1 121)
|
(1 188)
|
(1 158)
|
(1 166)
|
(1 196)
|
(1 203)
|
|
| Gross Profit |
152
N/A
|
183
+20%
|
174
-5%
|
170
-2%
|
194
+14%
|
213
+10%
|
214
+1%
|
187
-13%
|
151
-19%
|
199
+32%
|
239
+20%
|
272
+14%
|
276
+1%
|
270
-2%
|
268
-1%
|
|
| Operating Income | ||||||||||||||||
| Operating Expenses |
(123)
|
(42)
|
(0)
|
(28)
|
27
|
11
|
(89)
|
(122)
|
(112)
|
(187)
|
(115)
|
125
|
(96)
|
(109)
|
(108)
|
|
| Selling, General & Administrative |
(61)
|
(64)
|
(62)
|
(60)
|
(49)
|
(44)
|
(94)
|
(112)
|
(86)
|
(110)
|
(131)
|
(131)
|
(109)
|
(122)
|
(121)
|
|
| Depreciation & Amortization |
(3)
|
0
|
(3)
|
0
|
(3)
|
0
|
(4)
|
0
|
(10)
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Operating Expenses |
(60)
|
22
|
64
|
32
|
79
|
55
|
9
|
(10)
|
(17)
|
(77)
|
16
|
256
|
14
|
13
|
13
|
|
| Operating Income |
29
N/A
|
140
+387%
|
174
+24%
|
142
-18%
|
222
+56%
|
224
+1%
|
125
-44%
|
65
-48%
|
39
-41%
|
12
-69%
|
125
+938%
|
397
+218%
|
180
-55%
|
161
-11%
|
160
-1%
|
|
| Pre-Tax Income | ||||||||||||||||
| Interest Income Expense |
(12)
|
16
|
32
|
26
|
35
|
13
|
6
|
20
|
(108)
|
110
|
(129)
|
(540)
|
(106)
|
(123)
|
66
|
|
| Non-Reccuring Items |
0
|
0
|
(2)
|
(674)
|
(686)
|
(561)
|
(579)
|
(492)
|
(463)
|
(2)
|
224
|
224
|
(0)
|
165
|
(39)
|
|
| Total Other Income |
1
|
0
|
(8)
|
(14)
|
(7)
|
(3)
|
(1)
|
(0)
|
(0)
|
0
|
(4)
|
(7)
|
0
|
12
|
0
|
|
| Pre-Tax Income |
18
N/A
|
158
+781%
|
196
+24%
|
(519)
N/A
|
(436)
+16%
|
(327)
+25%
|
(449)
-37%
|
(408)
+9%
|
(533)
-31%
|
120
N/A
|
216
+80%
|
75
-65%
|
74
-1%
|
216
+192%
|
187
-13%
|
|
| Net Income | ||||||||||||||||
| Tax Provision |
(41)
|
(50)
|
(26)
|
27
|
15
|
62
|
87
|
18
|
4
|
(33)
|
(48)
|
(61)
|
(47)
|
(44)
|
(48)
|
|
| Income from Continuing Operations |
(23)
|
108
|
169
|
(492)
|
(421)
|
(265)
|
(362)
|
(389)
|
(529)
|
87
|
168
|
14
|
26
|
171
|
139
|
|
| Income to Minority Interest |
(27)
|
(38)
|
(19)
|
26
|
17
|
54
|
82
|
22
|
50
|
(11)
|
(37)
|
(29)
|
(52)
|
(23)
|
(3)
|
|
| Net Income (Common) |
(50)
N/A
|
70
N/A
|
151
+116%
|
(467)
N/A
|
(404)
+13%
|
(210)
+48%
|
(281)
-34%
|
(367)
-31%
|
(478)
-30%
|
76
N/A
|
131
+74%
|
(15)
N/A
|
(26)
-69%
|
148
N/A
|
136
-8%
|
|
| EPS (Diluted) |
-0.37
N/A
|
0.34
N/A
|
0.74
+118%
|
-3.37
N/A
|
-2.93
+13%
|
-1.52
+48%
|
-2.03
-34%
|
-2.66
-31%
|
-3.46
-30%
|
0.55
N/A
|
0.95
+73%
|
-0.11
N/A
|
-0.19
-73%
|
0.72
N/A
|
1
+39%
|
|
Switch to:
Switch to:
See Also
Discover More
